封面
市場調查報告書
商品編碼
1878064

醫用聚甲醛(POM)市場-2025-2030年預測

Medical Polyoxymethylene (POM) Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計醫用聚甲醛(POM)市場將從 2025 年的 84,981,000 美元成長到 2030 年的 108,511,000 美元,複合年成長率為 5.01%。

醫用級聚甲醛(POM),俗稱縮醛,是一種高性能工程熱塑性塑膠,因其優異的性能而在醫療產業備受青睞。醫用級POM經過特殊配方,可耐受多種消毒劑的反覆清洗,並可使用包括高溫蒸氣在內的標準方法進行滅菌。其高剛度、優異的尺寸穩定性、低摩擦係數和強耐化學性使其成為各種醫療應用的理想選擇。此外,其優異的生物相容性可防止與人體組織發生不良反應,這對於許多醫療設備至關重要。該材料主要有兩種形式:均聚物POM,具有高結晶質和高剛度;以及共聚物POM,具有更優異的抗氧化性和抗蠕變性等優點。

醫用聚甲醛(POM)市場的主要驅動力是全球對醫療器材與設備日益成長的需求。 POM廣泛應用於需要頻繁消毒和可靠性能的醫療設備製造,包括手術器械、整形外科植入和藥物傳輸系統。隨著醫療技術發展為更複雜的器械,POM的生物相容性和化學穩定性使其成為首選材料。醫療設備產業的成長,以及推薦使用具有安全可靠記錄的材料的嚴格監管標準,持續推動醫用POM的消費。這種聚合物的多功能性使其可應用於包括手術器械、植入式器械和診斷工具在內的廣泛領域,這與全球醫療機構對POM的消費量不斷成長相吻合。此外,醫療產業對永續材料日益成長的需求也推動了POM的使用。由於POM是一種可再生材料,製造商正在使用回收材料來減少對環境的影響。

按應用領域對醫用聚甲醛(POM)市場進行細分,揭示了幾個關鍵成長領域。透析設備是其中一個關鍵應用領域。這些對腎衰竭患者至關重要的設備,其零件需要具備耐化學性和耐久性,因此必須使用聚甲醛。糖尿病和高血壓等疾病在全球範圍內的日益流行,而這些疾病正是導致腎衰竭的主要原因,預計這將持續推動對透析設備的需求,進而帶動對醫用聚甲醛的需求。吸入器也是一個不斷成長的應用領域。空氣污染和室內空氣污染導致氣喘等呼吸系統疾病的增加,推動了定量噴霧吸入器的需求,而聚甲醛正是此類吸入器的理想材料。此外,胰島素筆的需求也是市場擴張的主要驅動力。全球糖尿病盛行率的不斷上升,促使人們需要更有效的糖尿病治療方法。胰島素筆依賴聚甲醛的耐用性、尺寸穩定性以及在各種條件下防止胰島素筆芯洩漏和損壞的能力,因此其應用越來越廣泛。這也推動了醫用聚甲醛在製造業領域的消耗。

從區域來看,亞太地區,尤其是中國,正經歷顯著的市場成長。這一成長主要得益於新興經濟體快速的工業化、都市化以及由此帶來的醫療基礎設施建設。政府所推行的產業扶持計畫等促進國內製造業發展的舉措,為醫療健康產業及其原料供應創造了有利環境。中國糖尿病盛行率較高,胰島素筆的使用也十分普遍,成為POM市場的主要驅動力。在政府加強醫療設施建設的措施支持下,中國蓬勃發展的醫療設備產業直接推動了POM的生產和消費。此外,消費者日益增強的環保意識以及對永續產品日益嚴格的監管,也促使消費者傾向選擇POM等環保材料,而非其他環保較差的替代方案。

北美市場預計也將顯著成長,這主要得益於許多成熟的國際醫療和製藥公司的存在。高昂的醫療保健支出和完善的醫療設備製造基地支撐著穩定的需求。尤其值得一提的是,腎衰竭發生率的上升帶動了透析設備需求的成長,進而推動了該地區處方藥消費量的成長。

該市場由全球主要化學製造商的產品供應支撐。這些公司提供符合嚴格監管要求的醫用級聚甲醛(POM)品牌產品。他們的產品系列涵蓋多種等級,專為高性能醫療應用而設計,並為醫療設備製造商提供材料選擇、設計最佳化和產品開發方面的全面技術支持,以確保最佳性能和合規性。

本報告的主要優勢:

  • 深入分析:獲得主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局:了解全球主要參與者的策略舉措,並了解透過正確的策略實現市場滲透的潛力。
  • 市場促進因素與未來趨勢:探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議:利用這些見解,在動態環境中做出策略決策,並開拓新的商機和收入來源。
  • 受眾廣泛:適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業,且經濟實惠。

企業使用我們的報告做什麼?

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍:

  • 2022年至2024年的歷史數據和2025年至2030年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區分類的收入成長和預測評估,包括國家/地區
  • 公司概況(策略、產品、財務資訊、關鍵發展等)

市場區隔:

  • 醫用聚甲醛(POM)市場按類型分類
  • 共聚物POM
  • 均聚物POM
  • 按應用分類的醫用聚甲醛 (POM) 市場
  • 透析設備
  • 吸入器
  • 醫療托盤
  • 手術器械
  • 胰島素筆
  • 藥用瓶蓋
  • 其他
  • 按最終用戶分類的醫用聚甲醛(POM)市場
  • 醫院和診所
  • 手術中心
  • 其他
  • 按地區分類的醫用聚甲醛(POM)市場
  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
  • 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 其他
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 醫用聚甲醛(POM)市場按類型分類

  • 介紹
  • 共聚物POM
  • 均聚物POM

6. 按應用分類的醫用聚甲醛(POM)市場

  • 介紹
  • 透析設備
  • 吸入器
  • 醫療托盤
  • 手術器械
  • 胰島素筆
  • 藥用瓶蓋
  • 其他

7. 依最終用戶分類的醫用聚甲醛 (POM) 市場

  • 介紹
  • 醫院和診所
  • 手術中心
  • 其他

8. 各地區醫用聚甲醛(POM)市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章:公司簡介

  • Celanese Corporation
  • BASF SE
  • Ensinger Group
  • Kolon Group
  • Barlog Plastics GmbH
  • SABIC
  • Asahi Kasei Corporation
  • Mitsubishi Chemical Corporation
  • Delrin USA, LLC
  • Polyplastics Co., Ltd

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061615231

The medical polyoxymethylene (POM) market is expected to grow at a CAGR of 5.01%, from US$ 84.981 million in 2025 to US$108.511 million in 2030.

Medical Polyoxymethylene (POM), commonly known as acetal, is a high-performance engineering thermoplastic valued in the healthcare industry for its exceptional properties. Medical-grade POM is specifically formulated to withstand repeated cleaning with various sanitizing solutions and can be sterilized using standard methods such as hot steam. Its unique combination of high stiffness, excellent dimensional stability, low friction coefficient, and strong chemical resistance makes it an ideal material for a wide range of medical applications. Furthermore, its inherent biocompatibility ensures it does not cause harmful reactions with human tissue, which is a prerequisite for many medical devices. The material is commercially available in two primary forms: homopolymer POM, which offers high crystallinity and stiffness, and copolymer POM, which provides benefits such as enhanced oxidation and creep resistance.

A primary driver for the medical POM market is the rising global demand for medical devices and equipment. POM is extensively utilized in manufacturing devices that require frequent sterilization and reliable performance, including surgical tools, orthopedic implants, and drug delivery systems. The biocompatibility and chemical invariance of POM make it a preferred material as medical technology advances toward more complex devices. The growth of the medical device industry, coupled with stringent regulatory standards that favor materials with a proven track record of safety and reliability, continues to propel the consumption of medical POM. The versatility of this polymer ensures its application across surgical instruments, implantable devices, and diagnostic tools, aligning with the increasing consumption of healthcare facilities worldwide. Additionally, the growing demand for sustainable materials in healthcare is fostering the use of POM, as it is a recyclable material, leading manufacturers to incorporate recycled content to reduce environmental footprint.

The application segmentation of the medical POM market reveals several key growth areas. Dialysis machines represent a significant application segment. These machines, essential for patients with kidney failure, utilize POM for components that require chemical resistance and durability. The increasing global prevalence of conditions like diabetes and hypertension, which are leading causes of kidney failure, is expected to sustain the demand for dialysis machines and, consequently, for medical POM. Inhalers constitute another expanding application. The rising incidence of respiratory ailments such as asthma, driven in part by ambient and household air pollution, is increasing the demand for metered-dose inhalers, for which POM is a suitable material. Furthermore, the demand for insulin pens is a major contributor to market expansion. The growing global diabetic population is driving the need for effective diabetes care options. Insulin pens, which rely on POM for their durability, dimensional stability, and ability to protect the insulin cartridge from leakage or damage under varying conditions, are seeing increased adoption, thereby fueling the consumption of medical POM in their manufacturing.

From a geographical perspective, the Asia Pacific region, and particularly China, is witnessing substantial market growth. This expansion is fueled by rapid industrialization, urbanization, and the consequent development of healthcare infrastructure in emerging economies. Government initiatives aimed at boosting domestic manufacturing, such as industrial promotion schemes, are creating favorable conditions for the medical industry and the materials that supply it. In China specifically, the high prevalence of diabetes has led to widespread adoption of insulin pens, making it a key driver for the POM market. The country's rapidly expanding medical device industry, supported by government efforts to enhance healthcare facilities, directly increases the production and consumption of POM. A growing customer awareness and regulatory push for sustainable products are also shifting preferences towards materials like POM over less environmentally friendly alternatives.

The North American market is also expected to grow significantly, driven by the presence of established international medical and pharmaceutical companies. High healthcare expenditure and a well-developed medical device manufacturing base contribute to steady demand. The growing need for devices such as dialysis machines, propelled by rising rates of kidney failure, is a specific factor increasing the consumption of medical POM in the region.

The market is supported by product offerings from leading global chemical companies. These corporations provide specialized medical-grade POM brands that comply with stringent regulatory requirements. Their product portfolios include various grades designed for high-performance medical applications, and they often provide extensive technical support to medical device manufacturers, assisting with material selection, design optimization, and product development to ensure optimal performance and compliance.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

  • MEDICAL POLYOXYMETHYLENE (POM) MARKET BY TYPE
  • Copolymer POM
  • Homopolymer POM
  • MEDICAL POLYOXYMETHYLENE (POM) MARKET BY APPLICATION
  • Dialysis Machine
  • Inhalers
  • Medical Trays
  • Surgical Instruments
  • Insulin Pen
  • Pharmaceutical Closures
  • Others
  • MEDICAL POLYOXYMETHYLENE (POM) MARKET BY END-USER
  • Hospital & Clincs
  • Surgical Centers
  • Others
  • MEDICAL POLYOXYMETHYLENE (POM) MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Copolymer POM
  • 5.3. Homopolymer POM

6. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Dialysis Machine
  • 6.3. Inhalers
  • 6.4. Medical Trays
  • 6.5. Surgical Instruments
  • 6.6. Insulin Pen
  • 6.7. Pharmaceutical Closures
  • 6.8. Others

7. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospital & Clincs
  • 7.3. Surgical Centers
  • 7.4. Others

8. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Celanese Corporation
  • 10.2. BASF SE
  • 10.3. Ensinger Group
  • 10.4. Kolon Group
  • 10.5. Barlog Plastics GmbH
  • 10.6. SABIC
  • 10.7. Asahi Kasei Corporation
  • 10.8. Mitsubishi Chemical Corporation
  • 10.9. Delrin USA, LLC
  • 10.10. Polyplastics Co., Ltd

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations